Research reports on effectiveness of Scriptaid in breast cancer cell lines

[News]

Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, PA, reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors.

More... (http://www.news-medical.net/news/20120118/Research-reports-on-effectiveness-of-Scriptaid-in-breast-cancer-cell-lines.aspx)